Stay updated on JNJ-63623872 Effect on Pitavastatin in Healthy Participants Clinical Trial

Sign up to get notified when there's something new on the JNJ-63623872 Effect on Pitavastatin in Healthy Participants Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JNJ-63623872 Effect on Pitavastatin in Healthy Participants Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, with the previous version v2.9.7 now removed.
    Difference
    0.3%
    Check dated 2024-07-23T14:28:43.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T06:29:19.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T13:13:33.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T09:39:10.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T08:33:20.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Show more Revision: v2.9.0' has recently changed to 'Show less Drug Information available for: Pitavastatin FDA Drug and Device Resources Show less Design Details Allocation : N/A Interventional Model : Single Group Assignment Masking : None (Open Label) Arms and Interventions Participant Group/Arm Intervention/Treatment Experimental : Pitavastatin Then JNJ-63623872 Participants will sequentially receive single oral dose of pitavastatin 1 milligram (mg) on Day 1, followed by JNJ-63623872 600 mg twice daily on Days 4 through 12 with a single oral dose of pitavastatin 1 mg administered in the morning of Day 9. All study drug intakes will be taken orally, under fed conditions (within approximately 10 minutes after completion of a meal). Drug : Pitavastatin Participants will receive single oral dose of pitavastatin 1 milligram (mg) on Day 1 and Day 9. Drug : JNJ-63623872 Participants will receive JNJ-63623872 600 mg twice daily on Days 4 through 12.' This change represents an update in the drug information and study design details for the clinical trial involving Pitavastatin and JNJ-63623872.
    Difference
    76%
    Check dated 2024-06-25T08:08:36.000Z thumbnail image

Stay in the know with updates to JNJ-63623872 Effect on Pitavastatin in Healthy Participants Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JNJ-63623872 Effect on Pitavastatin in Healthy Participants Clinical Trial page.